Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia

被引：0
|
作者：
Inomata, Minoru [1 ]
Miura, Yukiko [1 ]
Kokuho, Nariaki [1 ]
Hayashi, Hiroki [1 ]
Nei, Takahito [1 ]
Kamio, Koichiro [1 ]
Fujita, Kazue [1 ]
Saito, Yoshinobu [1 ]
Gemma, Akihiko [1 ]
Saito, Takefumi [2 ]
Azuma, Arata [1 ]
机构：
[1] Grad Sch Med, Nippon Med Sch, Dept Pulm Med & Oncol, Tokyo, Japan
[2] Ibaraki Higashi Natl Hosp, Dept Resp Med, Ibaraki, Japan
来源：
EUROPEAN RESPIRATORY JOURNAL | 2015年 / 46卷
关键词：
Idiopathic pulmonary fibrosis; Interstitial lung disease; Interstitial lung disease (connective tissue disease);
D O I：
10.1183/13993003.congress-2015.OA4497
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
OA4497
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Pharmacological Treatment for Acute Exacerbation of Fibrosing Interstitial Pneumonia: A Retrospective Study of 95 Patients
    Sakamoto, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [32] EFFICACY AND SAFETY OF MIZORIBINE ADMINISTERED IN PATIENTS WITH INTERSTITIAL PNEUMONIA
    Hamao, N.
    Masakuni, U.
    Terada, S.
    Nakanishi, T.
    Inao, T.
    Kaji, Y.
    Yasuda, T.
    Hashimoto, S.
    Hajiro, T.
    Tanaka, E.
    Taguchi, Y.
    RESPIROLOGY, 2016, 21 : 195 - 195
  • [33] Plasma Autotaxin Is a Novel Biomarker for Chronic Fibrosing Interstitial Pneumonia
    Isshiki, T.
    Shimizu, H.
    Yamasaki, A.
    Miyoshi, S.
    Nakamura, Y.
    Sakamoto, S.
    Homma, S. A.
    Kishi, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [34] Frequency and characteristics of refractory dyspnea in idiopathic fibrosing interstitial pneumonia
    Bautin, Nathalie
    Ferlin, Juliette
    Terce, Gaelle
    Ternynck, Camille
    Valentin, Victor
    Wemeau, Lidwine
    Chenivesse, Cecile
    RESPIRATORY MEDICINE, 2024, 222
  • [35] Clinicoradiological Features of Chronic Fibrosing Interstitial Pneumonia with Smoking History
    Kaga, A.
    Sakai, F.
    Usui, Y.
    Kobayashi, K.
    Nagata, M.
    Hagiwara, K.
    Kanazawa, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [36] The efficacy of pirfenidone in scleroderma related interstitial lung disease
    Miura, Yukiko
    Tsunoda, Yoshiya
    Tanaka, Toru
    Takoi, Hiroyuki
    Yatagai, Yohei
    Rin, Shigen
    Sekine, Akimasa
    Hayashihara, Kenji
    Saito, Takefumi
    Gemma, Akihiko
    Azuma, Arata
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [37] Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases
    Katzenstein, Anna-Luise A.
    Mukhopadhyay, Sanjay
    Myers, Jeffrey L.
    HUMAN PATHOLOGY, 2008, 39 (09) : 1275 - 1294
  • [38] Correlation Between Serum Monomeric Periostin And The Prognosis In Patients With Acute Exacerbation Of Fibrosing Interstitial Pneumonia
    Shimizu, H.
    Sakamoto, S.
    Isshiki, T.
    Urabe, N.
    Suzuki, A.
    Gocho, K.
    Sano, G.
    Sugino, K.
    Isobe, K.
    Takai, Y.
    Okamoto, M.
    Hoshino, T.
    Izuhara, K.
    Homma, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [39] PREDICTIVE FACTORS OF LONG-TERM USE OF PIRFENIDONE IN PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE
    Katano, Takuma
    Ikeda, Satoshi
    Yamaya, Takafumi
    Otoshi, Ryota
    Okabayashi, Hiroko
    Niwa, Takashi
    Kitamura, Hideya
    Ogura, Takashi
    RESPIROLOGY, 2019, 24 : 246 - 247
  • [40] DIAGNOSTIC SIGNIFICANCE OF BIOMARKERS FOR CHRONIC FIBROSING IDIOPATHIC INTERSTITIAL PNEUMONIAS (USUAL INTERSTITIAL PNEUMONIA VS NON-SPECIFIC INTERSTITIAL PNEUMONIA)
    Kato, M.
    Sasaki, S.
    Nakamura, K.
    Sakimoto, Y.
    Hayakawa, D.
    Aditya, W.
    Koinuma, Y.
    Ihara, H.
    Shimada, N.
    Nagashima, O.
    Yoshioka, Y.
    Takahashi, M.
    Takahashi, F.
    Tominaga, S.
    Takahashi, K.
    RESPIROLOGY, 2016, 21 : 199 - 199
12345